XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
A
A

AstraZeneca


Actualités

EMA's CHMP Gives Wainzua Positive Opinion for Treating Adults with Hereditary Amyloidosis

BRIEF-EMA's CHMP Gives Wainzua Positive Opinion for Treating Adults with Hereditary Amyloidosis Oct 18 (Reuters) - EMA's CHMP: WAINZUA GETS POSITIVE OPINION FOR TREATMENT OF ADULTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS Source text for Eikon: [ID:] Further company coverage: AZN.L
A

Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)

CORRECTED-Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17) Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory infections, not all lower respiratory infections Oct 17 (Reuters) - Merck MRK.N said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial virus (RSV)-associated infections in infants.
A
P
S
S

Consumer groups ask FTC to block Novo Holdings-Catalent deal

UPDATE 4-Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing Adds Roche comment in paragraph 8 By Jody Godoy and Maggie Fick NEW YORK, Oct 18 (Reuters) - U.S.
A
A
N
N
P
R

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing By Jody Godoy, Maggie Fick NEW YORK, Oct 17 (Reuters) - Five U.S. consumer groups and two large labor unions urged the U.S.
A
A
N
N
P
R

US natgas prices ease to 4-week low on mild weather forecasts

UPDATE 2-US natgas prices ease to 4-week low on mild weather forecasts Adds latest prices By Scott DiSavino Oct 17 (Reuters) - U.S. natural gas futures eased 1% to a four-week low on Thursday on forecasts for mild weather over the next two weeks that should keep heating demand lower than normal for this time of year. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 2.0 cents, or 0.8%, to settle at $2.347 per million British thermal units (mmBtu), their
A
N

US natgas prices edge up 1% on higher demand, ahead of storage report

US natgas prices edge up 1% on higher demand, ahead of storage report By Scott DiSavino Oct 17 (Reuters) - U.S. natural gas futures edged up about 1% on Thursday on forecasts for higher demand next week than previously expected. The small price move came ahead of a federal report expected to show that utilities last week added less gas to storage than usual for a 13th week in a row.
A
N

US natgas prices drop 5% to 3-week low as mild weather keeps demand low

UPDATE 1-US natgas prices drop 5% to 3-week low as mild weather keeps demand low Adds latest prices By Scott DiSavino Oct 16 (Reuters) - U.S. natural gas futures dropped about 5% to a three-week low on Wednesday on expectations mild weather over the next two weeks will keep demand low. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 13.1 cents, or 5.2%, to settle at $2.367 per million British thermal units (mmBtu), their lowest close since Sept.
A

UK's MHRA Approves Eplontersen To Treat Adults With Rare Inherited Nerve Disease

BRIEF-UK's MHRA Approves Eplontersen To Treat Adults With Rare Inherited Nerve Disease Oct 16 (Reuters) - UK's MHRA: EPLONTERSEN APPROVED TO TREAT ADULTS WITH RARE INHERITED NERVE DISEASE OR POLYNEUROPATHY Source text for Eikon: [ID:] Further company coverage: AZN.L
A

US natgas prices slide to 3-week low as mild weather keeps demand low

US natgas prices slide to 3-week low as mild weather keeps demand low By Scott DiSavino Oct 16 (Reuters) - U.S. natural gas futures slid about 3% to a three-week low on Wednesday on expectations mild weather over the next two weeks will keep demand low. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 6.7 cents, or 2.7%, to $2.431 per million British thermal units by 8:07 a.m.
A
N

US natgas prices hold near 3-week low on mild weather forecasts

UPDATE 1-US natgas prices hold near 3-week low on mild weather forecasts Adds latest prices By Scott DiSavino Oct 15 (Reuters) - U.S. natural gas futures settled near a three-week low on Tuesday on expectations mild weather over the next two weeks will keep demand low. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange rose 0.4 cents, or 0.2%, to settle at $2.498 per million British thermal units (mmBtu).
A

US natgas prices hold near 3-week low on mild weather forecasts

US natgas prices hold near 3-week low on mild weather forecasts By Scott DiSavino Oct 15 (Reuters) - U.S. natural gas futures held near a three-week low on Tuesday on expectations mild weather over the next two weeks will keep demand low. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange remained unchanged at $2.490 per million British thermal units (mmBtu) at 8:11 a.m.
A
N

US natgas prices drop 5% to 3-week low on reduced demand forecast

UPDATE 1-US natgas prices drop 5% to 3-week low on reduced demand forecast Adds latest prices By Scott DiSavino Oct 14 (Reuters) - U.S. natural gas futures dropped about 5% to a three -week low on Monday on forecasts for milder weather and less demand next week than previously expected. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 13.8 cents, or 5.2%, to settle at $2.494 per million British thermal units (mmBtu), their lowest close since Sept.
A
N

US natgas prices fall 3% to 2-week low on lower demand forecast

US natgas prices fall 3% to 2-week low on lower demand forecast By Scott DiSavino Oct 14 (Reuters) - U.S. natural gas futures dropped about 3% to two-week lows on Monday on forecasts for milder weather and less demand next week than previously expected. Front-month gas futures NGc1 for November delivery on the New York Mercantile Exchange fell 7.3 cents, or 2.8%, to $2.559 per million British thermal units (mmBtu) at 8:48 a.m.
A
N

AstraZeneca Announces Enhertu Approval In China

BRIEF-AstraZeneca Announces Enhertu Approval In China Oct 14 (Reuters) - AstraZeneca PLC AZN.L : ENHERTU APPROVED IN CHINA AS FIRST HER2-DIRECTED THERAPY FOR PATIENTS WITH HER2-MUTANT METASTATIC NON-SMALL CELL LUNG CANCER Source text for Eikon: ID:nWkr76Qr66 Further company coverage: AZN.L
A

US natgas prices slide 2% to 2-week low on Hurricane Milton power outages

UPDATE 1-US natgas prices slide 2% to 2-week low on Hurricane Milton power outages Adds latest prices By Scott DiSavino Oct 11 (Reuters) - U.S. natural gas futures slid about 2% to a two-week low on Friday as power generators burned less gas after Hurricane Milton knocked out power to millions of homes and businesses in Florida. The price decline came despite a decline in output so far this month and forecasts for the amount of gas flowing to liquefied natural gas (LNG) export plants to increase
A
N

US natgas prices edge up on forecast rise in LNG feedgas when Cove Point returns

US natgas prices edge up on forecast rise in LNG feedgas when Cove Point returns By Scott DiSavino Oct 11 (Reuters) - U.S. natural gas futures edged up about 1% on Thursday on lower output and a forecast increase in the amount of gas flowing to liquefied natural gas (LNG) export plants with the Cove Point facility in Maryland expected back soon. That small price increase came even though power generators were burning less gas after Hurricane Milton knocked out power to millions of homes and busi
A
N

Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7 - SEC Filing

BRIEF-Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7 - SEC Filing AstraZeneca PLC AZN.L : ASTRAZENECA PLC REPORTS 9.9% PASSIVE STAKE IN CONDUIT PHARMACEUTICALS INC AS OF AUGUST 7 - SEC FILING Source text for Eikon: [ID:n0001104659-24-107836] Further company coverage: AZN.L
A

US natgas prices edge up 1% on expected return of Cove Point LNG plant

UPDATE 2-US natgas prices edge up 1% on expected return of Cove Point LNG plant Adds latest prices By Scott DiSavino Oct 10 (Reuters) - U.S. natural gas futures edged up about 1 % on Thursday on forecasts for higher demand this week with an expected increase in the amount of gas flowing to liquefied natural gas (LNG) export plants once Cove Point in Maryland returns to service in coming days.
A
N

US natgas prices hit 2-week low after Hurricane Milton knocks out power in parts of Florida

US natgas prices hit 2-week low after Hurricane Milton knocks out power in parts of Florida By Scott DiSavino Oct 10 (Reuters) - U.S. natural gas futures fell about 2% to a two-week low on Thursday on forecasts for lower demand next week and expectations power generators will burn less gas after Hurricane Milton knocked out power to millions of homes and businesses in Florida.
A
N

Pfizer's cancer drug combo improves overall survival in late-stage study

Pfizer's cancer drug combo improves overall survival in late-stage study Oct 10 (Reuters) - Pfizer PFE.N said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of advanced prostate cancer in a late-stage study. The drug combination showed a significant improvement in the overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC) regardless of the presence of a mutation, compared to Xtandi alone, Pfizer sai
A
P



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques